IMPACT

Afua Nyarko among those highlighted in the BPS December Bulletin.

Research from the Department of Physics has shed new light on the way malignant cells change their shape and migration techniques to invade different types of tissue.

College of Science Research and Innovation Seed (SciRIS) awards fund projects based on collaborative research within the College of Science community and beyond.

The health-enhancing performance of a compound found in hops is dependent upon its interactions with intestinal microorganisms, new research by Oregon State biochemist shows.

When the global pandemic forced the closure of college science departments across the nation, Dr. Kari van Zee, Dr. Ryan Mehl, Dr. Rick Cooley, and graduate student Phil Zhu—department faculty and research members at Oregon State University—had to think fast to adapt their hands-on senior-level research methods course to support remote and hybrid models of learning.

Biophysicist Afua Nyarko has received $820K over a four-year period to conduct research into biological processes important for the regulation of cell growth, memory and kidney function. She hopes that her research will broaden the scope of scientific knowledge, opening new doors for disease treatment.

Ryan Mehl, professor of biochemistry and biophysics, has received two new grants that reflect the lab's growing success in genetic code expansion.

Research by Oregon State University suggests a pair of compounds originating from hops can help thwart a dangerous buildup of fat in the liver known as hepatic steatosis.

Biochemists at Oregon State University have found a key new piece of the puzzle in the quest to use gene therapy to enable people born deaf to hear.

On April 22, the College of Science celebrated its 2021 faculty and staff awards in a virtual ceremony, recognizing excellence in teaching, mentoring and advising.

The College of Science celebrated research and administrative excellence at its virtual 2021 awards ceremony on April 22.

Biochemists have taken a key step toward new drugs and vaccines for combating COVID-19 with a deep dive into one protein’s interactions with SARS-CoV-2 genetic material.